Functional Diagnostics in Minnesota

Carbon Medical Technologies, Inc. (formerly Advanced UroScience, Inc.) designs and manufactures implantable and minimally invasive medical devices using proprietary pyrolytic carbon coating technology. Founded in 1994, CMT is one of only five organizations worldwide with a dedicated pyrolytic carbon coating facility. The company specializes in devices for urological and oncological applications, with over 25 years of clinical use across 55+ countries and treatment of more than 1.4 million patients. CMT's primary product portfolio includes Durasphere® (an injectable bulking agent for stress urinary incontinence treatment), BiomarC® fiducial and tissue markers for radiation therapy and breast lesion localization, BiomarC® Restore for post-lumpectomy guidance, and the newly launched InjecSURE® cystoscopic injection system with female-specific anatomical design for urethral injections. The company operates under ISO 13485 and cGMP-compliant quality systems, maintains a validated ISO Class 7 cleanroom, and provides contract manufacturing services including design consultation, materials expertise, cleanroom assembly, and regulatory guidance. CMT supports multiple sterilization methods and manages the full product lifecycle from development through final delivery, positioning itself as a specialized provider for minimally invasive urology and oncology procedures.

BioMedix (Collaborative Care Diagnostics, LLC) is a vascular diagnostics company founded in 2004 specializing in non-invasive physiologic assessment systems for identifying peripheral artery disease (PAD) and managing population health in value-based care settings. The company's primary product line includes PADnet, a flexible and customizable vascular assessment system designed for clinical settings to detect hidden peripheral vascular disease through non-invasive testing, and PADnet Xpress, a portable, rapid screening solution optimized for population health management. BioMedix Xchange is a population health management platform that aggregates test results and patient history for centralized analysis and specialist review. The company enables secure remote transmission of test data and patient information to specialists for interpretation, supporting distributed care models and reducing patient travel burden. PADnet systems are used by podiatrists, primary care physicians, vascular surgeons, cardiologists, and interventional specialists across physician practices, hospitals, and health systems. Products integrate with multi-specialty groups to streamline workflow and improve care coordination between primary physicians and specialists. The company emphasizes training and support for clinical staff to ensure proper testing protocols and diagnostic confidence. Applications include screening high-risk populations (diabetics, smokers, patients over 65), evaluation of intermittent claudication and limb pain, identification of candidates for revascularization procedures, and ongoing management of vascular disease in value-based payment models. The platform supports seamless sharing of diagnostic results across care networks and remote specialist interpretation via secure internet-based systems.

Radiation Products Design, Inc. (RPD) is a specialized manufacturer and supplier of radiation therapy, diagnostic imaging, and nuclear medicine accessories and equipment. Based in Albertville, Minnesota, RPD serves medical physics, radiation oncology, and nuclear medicine departments across the United States. The company's product portfolio spans multiple therapeutic and diagnostic domains: radiation therapy positioning and immobilization systems (thermoplastic masks, vacuum cushions, head supports, breast positioning devices); brachytherapy applicators and accessories for both low-dose rate (LDR) and high-dose rate (HDR) gynecological applications; dosimetry and quality assurance equipment including build-up caps for ion chambers (Farmer, Exradin, PTW, Scanditronix/Wellhofer models), MOSFET and diode systems, electrometers, and radiation area monitors; CT simulator and imaging accessories such as CT chambers, phantoms, marking systems, and alignment lasers; shielding products including lead blocks, eye shields, tungsten shields, and mobile radiation barriers; calibration phantoms and water phantom systems; PET/nuclear medicine workstations, storage containers, and shipping systems; and sterilization/disinfection equipment and trays. RPD manufactures custom block room products (alloy dispensers, styrofoam blocks, cooling plates), bolus materials (Aquaplast, SuperFlab, moldable options), and precision beam modification tools. The company also supplies marking and positioning consumables, measuring instruments, lead-lined containers, and quality control devices (ISIS QA phantoms, beam analyzers). Products are compatible with major linear accelerator and imaging equipment manufacturers including Varian, Siemens, and Elekta. The company maintains a comprehensive PDF catalog and offers custom manufacturing for specialized applications. RPD serves hospital radiation oncology departments, medical physics groups, nuclear medicine facilities, and diagnostic imaging centers, providing both stock products and made-to-order solutions for radiation protection, dose verification, and treatment planning.

MedSource Labs is a U.S.-based medical device manufacturer founded in 2002 and headquartered in Chanhassen, Minnesota. The company specializes in developing and supplying Class II medical devices for IV therapy, respiratory care, and emergency care applications. Core product offerings include safety IV catheter lines, ETCO₂ sampling cannulas, and related emergency medical solutions. All products are manufactured in the U.S. and are TAA-compliant. The company employs approximately 40-98 people and generates annual revenue of approximately $28.6 million. MedSource Labs maintains an ISO-certified Quality Management System and holds multiple FDA 510(k) clearances and patents. The company operates its proprietary EMERGE development process to support full design, validation, and customization of medical device concepts through commercialization. MedSource Labs serves emergency medical providers, hospitals, government agencies, and global healthcare organizations through a diversified supply chain and distribution network.

MEDSPIRA LLC manufactures mcompass®, a portable, easy-to-use device for anorectal manometry and pelvic floor biofeedback therapy. The device is designed for integration into diverse care settings—gastroenterology, colorectal surgery, primary care, and other outpatient clinics—without requiring dedicated space or advanced operator training. mcompass combines diagnostic anorectal manometry with manometric biofeedback therapy capabilities, enabling clinicians to assess anorectal function (including rectoanal inhibitory reflex assessment via the Quick RAIR test) and treat pelvic floor dysfunction and defecation disorders in a single compact platform. The device uses disposable catheters and completes procedures in approximately 15 minutes. MEDSPIRA also operates an online store offering accessories and consumables. The company positions mcompass as a revenue-generating, patient-retention tool for practices seeking to provide comprehensive anorectal and pelvic floor diagnostics in-house rather than referring patients to specialized centers.

Nonin Medical, Inc. is a global leader in designing and manufacturing noninvasive physiological monitoring solutions. Founded in 1986 and headquartered in Plymouth, Minnesota, the company serves clinicians and consumers in over 125 countries. Nonin pioneered the world's first portable hand-held pulse oximeter and fingertip pulse oximeter, and was the first to integrate Bluetooth technology in pulse oximetry devices. The company's core product portfolio includes pulse oximeters (fingertip, wrist-worn, and handheld), regional/cerebral/somatic tissue oximeters, capnographs, and associated sensors. Nonin's proprietary PureSAT pulse oximetry technology provides accurate readings even in challenging conditions with motion, low perfusion, or variable skin tones. Primary customers include emergency medical services, hospitals, clinics, long-term care facilities, home healthcare providers, and OEM manufacturers who integrate Nonin components into their own medical devices. The company recently introduced the Nonin Health® platform, a cloud-based data management system enabling remote access to pulse oximetry results for improved workflow efficiency and clinical decision-making.

Monteris Medical Corp is a leader in minimally invasive laser ablation technology for neurosurgical applications. The company specializes in laser interstitial thermal therapy (LITT) systems designed specifically for brain procedures. Their flagship product, the NeuroBlate System, is an MR-guided robotic laser ablation platform indicated for treatment of brain tumors, radiation necrosis, and drug-resistant epilepsy. The system represents the only robotic MR-guided laser ablation tool in its class, delivering real-time thermal imaging and precision ablation capabilities for neurosurgical oncology and epilepsy applications. Monteris is committed to prospective multi-center clinical evidence generation, including participation in landmark studies such as LAANTERN to establish the safety and efficacy profile of LITT in brain applications. The company serves neurosurgical centers, academic medical centers, and specialized treatment facilities performing minimally invasive brain procedures. Products are designed for use in intraoperative MRI environments with integrated navigation and thermal monitoring. The company maintains a collaborative, innovation-focused organizational structure supporting product development and clinical evidence generation for minimally invasive neuroablation.